Skip to content

Comparison of the Metabolomic Effects of Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy

Comparison of the Metabolomic Effects of Sevoflurane and Desflurane Anesthesia in Laparoscopic Cholecystectomy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07399223
Enrollment
80
Registered
2026-02-10
Start date
2026-02-01
Completion date
2026-05-30
Last updated
2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolomic Effect, Sevoflurane Desflurane

Brief summary

Analytical techniques used in metabolomic studies include nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). The study will involve comparing the metabolomic profiles of patients receiving sevoflurane and desflurane during surgery to identify any differences in metabolic pathways affected by the two anaesthetic techniques. Metabolomic profiles are generated using spectroscopic and spectrometric techniques such as high-field NMR and MS, as well as separation techniques.

Detailed description

Our study will include 100 patients undergoing laparoscopic cholecystectomy surgery, divided into two groups. Patients aged 18-65 years with an ASA I-II classification, who will undergo laparoscopic cholecystectomy surgery, have no active infection, and have a body mass index (BMI) \<35, and who agree to participate in the study, will be intubated after standard anaesthetic induction (propofol, rocuronium, fentanyl) and intubated. The first sample will be taken from the finger immediately after the inhalation anaesthetic (sevoflurane, desflurane) reaches 1 minimal alveolar concentration (MAC) level. The second sample will be taken after the surgical procedure is completed and the inhalation anaesthesia is discontinued. The samples will be taken from the patients' fingertips and absorbed onto Guthrie paper. Statistical analysis will be performed on the data obtained.

Interventions

PROCEDUREDesflurane

This group will be operated on under desflurane.

PROCEDURESevoflurane

This group will be operated on under sevoflurane.

Sponsors

Harran University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing laparoscopic cholecystectomy surgery who have no active infection, Body mass index (BMI)\<35, Aged 18-65, ASA I-II, and who agree to participate in the study

Exclusion criteria

* Individuals over 65 years of age ASA 3-4 patients Individuals with a body mass index (BMI) \>35 Smokers

Design outcomes

Primary

MeasureTime frame
amino acid metabolism12 weeks
Our primary outcome measure will be the effect of both inhalation anaesthetics on amino acid metabolism.12 weeks

Contacts

CONTACTAhmet Atlas
ahmetatlas@harran.edu.tr+905322524176

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026